Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


New research suggests MS patients who suffer from fatigue and have limited use of their legs...

Positive results from a late-stage clinical trial of ozanimod could make way for another effective multiple sclerosis (MS) treatment. 

In the Celegen clinical trial, dubbed “Sunbeam”, two...

New research from Dr Paolo Muraro, of the Department of Medicine at Imperial College London and his colleagues recently reported further evidence of autologous hematopoietic stem cell...

Two clinical trials investigating the long-term effects of Lemtrada (alemtuzmab) in multiple sclerosis (MS) patients has revealed that the drug maintained outcomes, even in the absence of further...

High salt diets have been seen as a potential risk factor for MS in the past, but a new study has brought the subject to the fore once again, after researchers presented data which found a high...

New findings from a study by Merck KGaA, Darmstaft, Germany, a science and technology company operating as EMD Serono in Canada has shown that Cladribine Tablets can reduce brain atrophy, the rate...

Digesting Science has been awarded for its efforts in teaching young children about multiple sclerosis. The Queen Mary University of London (QMUL) Engagement and  Enterprise Awards 2017 recognise...

A drug, which has already been approved by the Food and Drug Federation has been found to supress chronic inflammation in the central nervous system in a mouse study. 

A research team led...

A major new study has revealed people who inherit genetic variants affecting the function of their immune system are at increased risk of developing the most common form of leukaemia.

...

Pages

Live Chat Software by Click4Assistance UK